Clinical outcomes of home parenteral nutrition patients using taurolidine as catheter lock: A long-term cohort study
Central venous access device (CVAD)-related complications, such as central-line associated bloodstream infections (CLABSIs), CVAD-related venous thromboses (CRVTs) and –occlusions frequently occur in home parenteral nutrition (HPN) patients. A preventive strategy to decrease the incidence of CLABSIs...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
Wouters, Yannick [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2019 |
|---|
| Schlagwörter: |
|---|
| Umfang: |
9 |
|---|
| Übergeordnetes Werk: |
Enthalten in: Tip Avalanche Photodiode—A spherical-junction SiPM concept - Vinogradov, S. ELSEVIER, 2022, the official journal of the European Society of Parenteral & Enteral Nutrition, Amsterdam [u.a.] |
|---|---|
| Übergeordnetes Werk: |
volume:38 ; year:2019 ; number:5 ; pages:2210-2218 ; extent:9 |
| Links: |
|---|
| DOI / URN: |
10.1016/j.clnu.2018.09.020 |
|---|
| Katalog-ID: |
ELV048038563 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV048038563 | ||
| 003 | DE-627 | ||
| 005 | 20230624142513.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 191023s2019 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.clnu.2018.09.020 |2 doi | |
| 028 | 5 | 2 | |a /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001106.pica |
| 035 | |a (DE-627)ELV048038563 | ||
| 035 | |a (ELSEVIER)S0261-5614(18)32458-0 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 530 |q VZ |
| 084 | |a 33.05 |2 bkl | ||
| 084 | |a 33.07 |2 bkl | ||
| 084 | |a 33.40 |2 bkl | ||
| 100 | 1 | |a Wouters, Yannick |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Clinical outcomes of home parenteral nutrition patients using taurolidine as catheter lock: A long-term cohort study |
| 264 | 1 | |c 2019 | |
| 300 | |a 9 | ||
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a Central venous access device (CVAD)-related complications, such as central-line associated bloodstream infections (CLABSIs), CVAD-related venous thromboses (CRVTs) and –occlusions frequently occur in home parenteral nutrition (HPN) patients. A preventive strategy to decrease the incidence of CLABSIs is the use of CVAD lock solutions, such as 2% taurolidine. The aim of this study was to evaluate long-term clinical outcomes of our HPN cohort while using taurolidine as lock solution. In addition, we explored risk factors associated with CVAD-related complications. | ||
| 650 | 7 | |a Catheter lock solution |2 Elsevier | |
| 650 | 7 | |a Intestinal failure |2 Elsevier | |
| 650 | 7 | |a Long-term outcomes |2 Elsevier | |
| 650 | 7 | |a Central line-associated bloodstream infection |2 Elsevier | |
| 650 | 7 | |a Home parenteral nutrition |2 Elsevier | |
| 650 | 7 | |a Taurolidine |2 Elsevier | |
| 700 | 1 | |a Roosenboom, Britt |4 oth | |
| 700 | 1 | |a Causevic, Erna |4 oth | |
| 700 | 1 | |a Kievit, Wietske |4 oth | |
| 700 | 1 | |a Groenewoud, Hans |4 oth | |
| 700 | 1 | |a Wanten, Geert J.A. |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |n Elsevier |a Vinogradov, S. ELSEVIER |t Tip Avalanche Photodiode—A spherical-junction SiPM concept |d 2022 |d the official journal of the European Society of Parenteral & Enteral Nutrition |g Amsterdam [u.a.] |w (DE-627)ELV008775001 |
| 773 | 1 | 8 | |g volume:38 |g year:2019 |g number:5 |g pages:2210-2218 |g extent:9 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.clnu.2018.09.020 |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 912 | |a SYSFLAG_U | ||
| 936 | b | k | |a 33.05 |j Experimentalphysik |q VZ |
| 936 | b | k | |a 33.07 |j Spektroskopie |q VZ |
| 936 | b | k | |a 33.40 |j Kernphysik |q VZ |
| 951 | |a AR | ||
| 952 | |d 38 |j 2019 |e 5 |h 2210-2218 |g 9 | ||
| author_variant |
y w yw |
|---|---|
| matchkey_str |
woutersyannickroosenboombrittcausevicern:2019----:lnclucmsfoeaetrlurtoptetuigarldnacte |
| hierarchy_sort_str |
2019 |
| bklnumber |
33.05 33.07 33.40 |
| publishDate |
2019 |
| allfields |
10.1016/j.clnu.2018.09.020 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001106.pica (DE-627)ELV048038563 (ELSEVIER)S0261-5614(18)32458-0 DE-627 ger DE-627 rakwb eng 530 VZ 33.05 bkl 33.07 bkl 33.40 bkl Wouters, Yannick verfasserin aut Clinical outcomes of home parenteral nutrition patients using taurolidine as catheter lock: A long-term cohort study 2019 9 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Central venous access device (CVAD)-related complications, such as central-line associated bloodstream infections (CLABSIs), CVAD-related venous thromboses (CRVTs) and –occlusions frequently occur in home parenteral nutrition (HPN) patients. A preventive strategy to decrease the incidence of CLABSIs is the use of CVAD lock solutions, such as 2% taurolidine. The aim of this study was to evaluate long-term clinical outcomes of our HPN cohort while using taurolidine as lock solution. In addition, we explored risk factors associated with CVAD-related complications. Catheter lock solution Elsevier Intestinal failure Elsevier Long-term outcomes Elsevier Central line-associated bloodstream infection Elsevier Home parenteral nutrition Elsevier Taurolidine Elsevier Roosenboom, Britt oth Causevic, Erna oth Kievit, Wietske oth Groenewoud, Hans oth Wanten, Geert J.A. oth Enthalten in Elsevier Vinogradov, S. ELSEVIER Tip Avalanche Photodiode—A spherical-junction SiPM concept 2022 the official journal of the European Society of Parenteral & Enteral Nutrition Amsterdam [u.a.] (DE-627)ELV008775001 volume:38 year:2019 number:5 pages:2210-2218 extent:9 https://doi.org/10.1016/j.clnu.2018.09.020 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 33.05 Experimentalphysik VZ 33.07 Spektroskopie VZ 33.40 Kernphysik VZ AR 38 2019 5 2210-2218 9 |
| spelling |
10.1016/j.clnu.2018.09.020 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001106.pica (DE-627)ELV048038563 (ELSEVIER)S0261-5614(18)32458-0 DE-627 ger DE-627 rakwb eng 530 VZ 33.05 bkl 33.07 bkl 33.40 bkl Wouters, Yannick verfasserin aut Clinical outcomes of home parenteral nutrition patients using taurolidine as catheter lock: A long-term cohort study 2019 9 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Central venous access device (CVAD)-related complications, such as central-line associated bloodstream infections (CLABSIs), CVAD-related venous thromboses (CRVTs) and –occlusions frequently occur in home parenteral nutrition (HPN) patients. A preventive strategy to decrease the incidence of CLABSIs is the use of CVAD lock solutions, such as 2% taurolidine. The aim of this study was to evaluate long-term clinical outcomes of our HPN cohort while using taurolidine as lock solution. In addition, we explored risk factors associated with CVAD-related complications. Catheter lock solution Elsevier Intestinal failure Elsevier Long-term outcomes Elsevier Central line-associated bloodstream infection Elsevier Home parenteral nutrition Elsevier Taurolidine Elsevier Roosenboom, Britt oth Causevic, Erna oth Kievit, Wietske oth Groenewoud, Hans oth Wanten, Geert J.A. oth Enthalten in Elsevier Vinogradov, S. ELSEVIER Tip Avalanche Photodiode—A spherical-junction SiPM concept 2022 the official journal of the European Society of Parenteral & Enteral Nutrition Amsterdam [u.a.] (DE-627)ELV008775001 volume:38 year:2019 number:5 pages:2210-2218 extent:9 https://doi.org/10.1016/j.clnu.2018.09.020 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 33.05 Experimentalphysik VZ 33.07 Spektroskopie VZ 33.40 Kernphysik VZ AR 38 2019 5 2210-2218 9 |
| allfields_unstemmed |
10.1016/j.clnu.2018.09.020 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001106.pica (DE-627)ELV048038563 (ELSEVIER)S0261-5614(18)32458-0 DE-627 ger DE-627 rakwb eng 530 VZ 33.05 bkl 33.07 bkl 33.40 bkl Wouters, Yannick verfasserin aut Clinical outcomes of home parenteral nutrition patients using taurolidine as catheter lock: A long-term cohort study 2019 9 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Central venous access device (CVAD)-related complications, such as central-line associated bloodstream infections (CLABSIs), CVAD-related venous thromboses (CRVTs) and –occlusions frequently occur in home parenteral nutrition (HPN) patients. A preventive strategy to decrease the incidence of CLABSIs is the use of CVAD lock solutions, such as 2% taurolidine. The aim of this study was to evaluate long-term clinical outcomes of our HPN cohort while using taurolidine as lock solution. In addition, we explored risk factors associated with CVAD-related complications. Catheter lock solution Elsevier Intestinal failure Elsevier Long-term outcomes Elsevier Central line-associated bloodstream infection Elsevier Home parenteral nutrition Elsevier Taurolidine Elsevier Roosenboom, Britt oth Causevic, Erna oth Kievit, Wietske oth Groenewoud, Hans oth Wanten, Geert J.A. oth Enthalten in Elsevier Vinogradov, S. ELSEVIER Tip Avalanche Photodiode—A spherical-junction SiPM concept 2022 the official journal of the European Society of Parenteral & Enteral Nutrition Amsterdam [u.a.] (DE-627)ELV008775001 volume:38 year:2019 number:5 pages:2210-2218 extent:9 https://doi.org/10.1016/j.clnu.2018.09.020 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 33.05 Experimentalphysik VZ 33.07 Spektroskopie VZ 33.40 Kernphysik VZ AR 38 2019 5 2210-2218 9 |
| allfieldsGer |
10.1016/j.clnu.2018.09.020 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001106.pica (DE-627)ELV048038563 (ELSEVIER)S0261-5614(18)32458-0 DE-627 ger DE-627 rakwb eng 530 VZ 33.05 bkl 33.07 bkl 33.40 bkl Wouters, Yannick verfasserin aut Clinical outcomes of home parenteral nutrition patients using taurolidine as catheter lock: A long-term cohort study 2019 9 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Central venous access device (CVAD)-related complications, such as central-line associated bloodstream infections (CLABSIs), CVAD-related venous thromboses (CRVTs) and –occlusions frequently occur in home parenteral nutrition (HPN) patients. A preventive strategy to decrease the incidence of CLABSIs is the use of CVAD lock solutions, such as 2% taurolidine. The aim of this study was to evaluate long-term clinical outcomes of our HPN cohort while using taurolidine as lock solution. In addition, we explored risk factors associated with CVAD-related complications. Catheter lock solution Elsevier Intestinal failure Elsevier Long-term outcomes Elsevier Central line-associated bloodstream infection Elsevier Home parenteral nutrition Elsevier Taurolidine Elsevier Roosenboom, Britt oth Causevic, Erna oth Kievit, Wietske oth Groenewoud, Hans oth Wanten, Geert J.A. oth Enthalten in Elsevier Vinogradov, S. ELSEVIER Tip Avalanche Photodiode—A spherical-junction SiPM concept 2022 the official journal of the European Society of Parenteral & Enteral Nutrition Amsterdam [u.a.] (DE-627)ELV008775001 volume:38 year:2019 number:5 pages:2210-2218 extent:9 https://doi.org/10.1016/j.clnu.2018.09.020 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 33.05 Experimentalphysik VZ 33.07 Spektroskopie VZ 33.40 Kernphysik VZ AR 38 2019 5 2210-2218 9 |
| allfieldsSound |
10.1016/j.clnu.2018.09.020 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001106.pica (DE-627)ELV048038563 (ELSEVIER)S0261-5614(18)32458-0 DE-627 ger DE-627 rakwb eng 530 VZ 33.05 bkl 33.07 bkl 33.40 bkl Wouters, Yannick verfasserin aut Clinical outcomes of home parenteral nutrition patients using taurolidine as catheter lock: A long-term cohort study 2019 9 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Central venous access device (CVAD)-related complications, such as central-line associated bloodstream infections (CLABSIs), CVAD-related venous thromboses (CRVTs) and –occlusions frequently occur in home parenteral nutrition (HPN) patients. A preventive strategy to decrease the incidence of CLABSIs is the use of CVAD lock solutions, such as 2% taurolidine. The aim of this study was to evaluate long-term clinical outcomes of our HPN cohort while using taurolidine as lock solution. In addition, we explored risk factors associated with CVAD-related complications. Catheter lock solution Elsevier Intestinal failure Elsevier Long-term outcomes Elsevier Central line-associated bloodstream infection Elsevier Home parenteral nutrition Elsevier Taurolidine Elsevier Roosenboom, Britt oth Causevic, Erna oth Kievit, Wietske oth Groenewoud, Hans oth Wanten, Geert J.A. oth Enthalten in Elsevier Vinogradov, S. ELSEVIER Tip Avalanche Photodiode—A spherical-junction SiPM concept 2022 the official journal of the European Society of Parenteral & Enteral Nutrition Amsterdam [u.a.] (DE-627)ELV008775001 volume:38 year:2019 number:5 pages:2210-2218 extent:9 https://doi.org/10.1016/j.clnu.2018.09.020 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 33.05 Experimentalphysik VZ 33.07 Spektroskopie VZ 33.40 Kernphysik VZ AR 38 2019 5 2210-2218 9 |
| language |
English |
| source |
Enthalten in Tip Avalanche Photodiode—A spherical-junction SiPM concept Amsterdam [u.a.] volume:38 year:2019 number:5 pages:2210-2218 extent:9 |
| sourceStr |
Enthalten in Tip Avalanche Photodiode—A spherical-junction SiPM concept Amsterdam [u.a.] volume:38 year:2019 number:5 pages:2210-2218 extent:9 |
| format_phy_str_mv |
Article |
| bklname |
Experimentalphysik Spektroskopie Kernphysik |
| institution |
findex.gbv.de |
| topic_facet |
Catheter lock solution Intestinal failure Long-term outcomes Central line-associated bloodstream infection Home parenteral nutrition Taurolidine |
| dewey-raw |
530 |
| isfreeaccess_bool |
false |
| container_title |
Tip Avalanche Photodiode—A spherical-junction SiPM concept |
| authorswithroles_txt_mv |
Wouters, Yannick @@aut@@ Roosenboom, Britt @@oth@@ Causevic, Erna @@oth@@ Kievit, Wietske @@oth@@ Groenewoud, Hans @@oth@@ Wanten, Geert J.A. @@oth@@ |
| publishDateDaySort_date |
2019-01-01T00:00:00Z |
| hierarchy_top_id |
ELV008775001 |
| dewey-sort |
3530 |
| id |
ELV048038563 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV048038563</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624142513.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">191023s2019 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.clnu.2018.09.020</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">/cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001106.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV048038563</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0261-5614(18)32458-0</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">530</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">33.05</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">33.07</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">33.40</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Wouters, Yannick</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Clinical outcomes of home parenteral nutrition patients using taurolidine as catheter lock: A long-term cohort study</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2019</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">9</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Central venous access device (CVAD)-related complications, such as central-line associated bloodstream infections (CLABSIs), CVAD-related venous thromboses (CRVTs) and –occlusions frequently occur in home parenteral nutrition (HPN) patients. A preventive strategy to decrease the incidence of CLABSIs is the use of CVAD lock solutions, such as 2% taurolidine. The aim of this study was to evaluate long-term clinical outcomes of our HPN cohort while using taurolidine as lock solution. In addition, we explored risk factors associated with CVAD-related complications.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Catheter lock solution</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Intestinal failure</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Long-term outcomes</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Central line-associated bloodstream infection</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Home parenteral nutrition</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Taurolidine</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Roosenboom, Britt</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Causevic, Erna</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kievit, Wietske</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Groenewoud, Hans</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Wanten, Geert J.A.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier</subfield><subfield code="a">Vinogradov, S. ELSEVIER</subfield><subfield code="t">Tip Avalanche Photodiode—A spherical-junction SiPM concept</subfield><subfield code="d">2022</subfield><subfield code="d">the official journal of the European Society of Parenteral & Enteral Nutrition</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV008775001</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:38</subfield><subfield code="g">year:2019</subfield><subfield code="g">number:5</subfield><subfield code="g">pages:2210-2218</subfield><subfield code="g">extent:9</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.clnu.2018.09.020</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">33.05</subfield><subfield code="j">Experimentalphysik</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">33.07</subfield><subfield code="j">Spektroskopie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">33.40</subfield><subfield code="j">Kernphysik</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">38</subfield><subfield code="j">2019</subfield><subfield code="e">5</subfield><subfield code="h">2210-2218</subfield><subfield code="g">9</subfield></datafield></record></collection>
|
| author |
Wouters, Yannick |
| spellingShingle |
Wouters, Yannick ddc 530 bkl 33.05 bkl 33.07 bkl 33.40 Elsevier Catheter lock solution Elsevier Intestinal failure Elsevier Long-term outcomes Elsevier Central line-associated bloodstream infection Elsevier Home parenteral nutrition Elsevier Taurolidine Clinical outcomes of home parenteral nutrition patients using taurolidine as catheter lock: A long-term cohort study |
| authorStr |
Wouters, Yannick |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV008775001 |
| format |
electronic Article |
| dewey-ones |
530 - Physics |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
530 VZ 33.05 bkl 33.07 bkl 33.40 bkl Clinical outcomes of home parenteral nutrition patients using taurolidine as catheter lock: A long-term cohort study Catheter lock solution Elsevier Intestinal failure Elsevier Long-term outcomes Elsevier Central line-associated bloodstream infection Elsevier Home parenteral nutrition Elsevier Taurolidine Elsevier |
| topic |
ddc 530 bkl 33.05 bkl 33.07 bkl 33.40 Elsevier Catheter lock solution Elsevier Intestinal failure Elsevier Long-term outcomes Elsevier Central line-associated bloodstream infection Elsevier Home parenteral nutrition Elsevier Taurolidine |
| topic_unstemmed |
ddc 530 bkl 33.05 bkl 33.07 bkl 33.40 Elsevier Catheter lock solution Elsevier Intestinal failure Elsevier Long-term outcomes Elsevier Central line-associated bloodstream infection Elsevier Home parenteral nutrition Elsevier Taurolidine |
| topic_browse |
ddc 530 bkl 33.05 bkl 33.07 bkl 33.40 Elsevier Catheter lock solution Elsevier Intestinal failure Elsevier Long-term outcomes Elsevier Central line-associated bloodstream infection Elsevier Home parenteral nutrition Elsevier Taurolidine |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
b r br e c ec w k wk h g hg g j w gj gjw |
| hierarchy_parent_title |
Tip Avalanche Photodiode—A spherical-junction SiPM concept |
| hierarchy_parent_id |
ELV008775001 |
| dewey-tens |
530 - Physics |
| hierarchy_top_title |
Tip Avalanche Photodiode—A spherical-junction SiPM concept |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV008775001 |
| title |
Clinical outcomes of home parenteral nutrition patients using taurolidine as catheter lock: A long-term cohort study |
| ctrlnum |
(DE-627)ELV048038563 (ELSEVIER)S0261-5614(18)32458-0 |
| title_full |
Clinical outcomes of home parenteral nutrition patients using taurolidine as catheter lock: A long-term cohort study |
| author_sort |
Wouters, Yannick |
| journal |
Tip Avalanche Photodiode—A spherical-junction SiPM concept |
| journalStr |
Tip Avalanche Photodiode—A spherical-junction SiPM concept |
| lang_code |
eng |
| isOA_bool |
false |
| dewey-hundreds |
500 - Science |
| recordtype |
marc |
| publishDateSort |
2019 |
| contenttype_str_mv |
zzz |
| container_start_page |
2210 |
| author_browse |
Wouters, Yannick |
| container_volume |
38 |
| physical |
9 |
| class |
530 VZ 33.05 bkl 33.07 bkl 33.40 bkl |
| format_se |
Elektronische Aufsätze |
| author-letter |
Wouters, Yannick |
| doi_str_mv |
10.1016/j.clnu.2018.09.020 |
| dewey-full |
530 |
| title_sort |
clinical outcomes of home parenteral nutrition patients using taurolidine as catheter lock: a long-term cohort study |
| title_auth |
Clinical outcomes of home parenteral nutrition patients using taurolidine as catheter lock: A long-term cohort study |
| abstract |
Central venous access device (CVAD)-related complications, such as central-line associated bloodstream infections (CLABSIs), CVAD-related venous thromboses (CRVTs) and –occlusions frequently occur in home parenteral nutrition (HPN) patients. A preventive strategy to decrease the incidence of CLABSIs is the use of CVAD lock solutions, such as 2% taurolidine. The aim of this study was to evaluate long-term clinical outcomes of our HPN cohort while using taurolidine as lock solution. In addition, we explored risk factors associated with CVAD-related complications. |
| abstractGer |
Central venous access device (CVAD)-related complications, such as central-line associated bloodstream infections (CLABSIs), CVAD-related venous thromboses (CRVTs) and –occlusions frequently occur in home parenteral nutrition (HPN) patients. A preventive strategy to decrease the incidence of CLABSIs is the use of CVAD lock solutions, such as 2% taurolidine. The aim of this study was to evaluate long-term clinical outcomes of our HPN cohort while using taurolidine as lock solution. In addition, we explored risk factors associated with CVAD-related complications. |
| abstract_unstemmed |
Central venous access device (CVAD)-related complications, such as central-line associated bloodstream infections (CLABSIs), CVAD-related venous thromboses (CRVTs) and –occlusions frequently occur in home parenteral nutrition (HPN) patients. A preventive strategy to decrease the incidence of CLABSIs is the use of CVAD lock solutions, such as 2% taurolidine. The aim of this study was to evaluate long-term clinical outcomes of our HPN cohort while using taurolidine as lock solution. In addition, we explored risk factors associated with CVAD-related complications. |
| collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U |
| container_issue |
5 |
| title_short |
Clinical outcomes of home parenteral nutrition patients using taurolidine as catheter lock: A long-term cohort study |
| url |
https://doi.org/10.1016/j.clnu.2018.09.020 |
| remote_bool |
true |
| author2 |
Roosenboom, Britt Causevic, Erna Kievit, Wietske Groenewoud, Hans Wanten, Geert J.A. |
| author2Str |
Roosenboom, Britt Causevic, Erna Kievit, Wietske Groenewoud, Hans Wanten, Geert J.A. |
| ppnlink |
ELV008775001 |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth oth oth oth oth |
| doi_str |
10.1016/j.clnu.2018.09.020 |
| up_date |
2024-07-06T17:47:36.862Z |
| _version_ |
1803852769514225664 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV048038563</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624142513.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">191023s2019 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.clnu.2018.09.020</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">/cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001106.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV048038563</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0261-5614(18)32458-0</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">530</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">33.05</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">33.07</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">33.40</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Wouters, Yannick</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Clinical outcomes of home parenteral nutrition patients using taurolidine as catheter lock: A long-term cohort study</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2019</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">9</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Central venous access device (CVAD)-related complications, such as central-line associated bloodstream infections (CLABSIs), CVAD-related venous thromboses (CRVTs) and –occlusions frequently occur in home parenteral nutrition (HPN) patients. A preventive strategy to decrease the incidence of CLABSIs is the use of CVAD lock solutions, such as 2% taurolidine. The aim of this study was to evaluate long-term clinical outcomes of our HPN cohort while using taurolidine as lock solution. In addition, we explored risk factors associated with CVAD-related complications.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Catheter lock solution</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Intestinal failure</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Long-term outcomes</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Central line-associated bloodstream infection</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Home parenteral nutrition</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Taurolidine</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Roosenboom, Britt</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Causevic, Erna</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kievit, Wietske</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Groenewoud, Hans</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Wanten, Geert J.A.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier</subfield><subfield code="a">Vinogradov, S. ELSEVIER</subfield><subfield code="t">Tip Avalanche Photodiode—A spherical-junction SiPM concept</subfield><subfield code="d">2022</subfield><subfield code="d">the official journal of the European Society of Parenteral & Enteral Nutrition</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV008775001</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:38</subfield><subfield code="g">year:2019</subfield><subfield code="g">number:5</subfield><subfield code="g">pages:2210-2218</subfield><subfield code="g">extent:9</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.clnu.2018.09.020</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">33.05</subfield><subfield code="j">Experimentalphysik</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">33.07</subfield><subfield code="j">Spektroskopie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">33.40</subfield><subfield code="j">Kernphysik</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">38</subfield><subfield code="j">2019</subfield><subfield code="e">5</subfield><subfield code="h">2210-2218</subfield><subfield code="g">9</subfield></datafield></record></collection>
|
| score |
7.398983 |